This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ONT-10

Cascadian Therapeutics, Inc.

Drug Names(s): ONT-10

Description: ONT-10 is Oncothyreon's proprietary follow-on vaccine to Stimuvax. ONT-10 is a therapeutic vaccine targeting MUC1, designed to stimulate both the humoral and cellular arms of the immune response. The adjuvant component of ONT-10 is PET-Lipid A, a fully synthetic toll like receptor 4 (TLR4) agonist.


ONT-10 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug